News Category
Scinai Immunotherapeutics strengthens its CDMO operations with the appointment of a seasoned supply chain leader, positioning the company for expanded...
Quantum BioPharma announced that patient enrollment in its collaborative MS imaging study with Massachusetts General Hospital has reached 50%, with pr...
The article discusses Oncotelic Therapeutics' featured editorial on CNS drug delivery challenges and its strategic monetization agreement with Lunai B...
Oncotelic Therapeutics is featured in a BioMedWire editorial for its intranasal nose-to-brain delivery platform that bypasses the blood-brain barrier,...
Oncotelic Therapeutics emphasizes its partnership-driven approach, including a joint venture with GMP Biotechnology that added $249 million to its bal...
The Sartorius AG Supervisory Board has extended Dr. René Fáber's appointment as Executive Board member to December 2031, ensuring continued leadership...
Scinai Immunotherapeutics received a Nasdaq notice for failing to maintain the minimum bid price, but has a 180-day period to regain compliance, with ...
SGX945 (dusquetide) has been granted PIM designation by the UK MHRA, potentially leading to early access for patients with Behcet's Disease based on p...
Silo Pharma's board authorized a $1 million share repurchase program, signaling confidence in the company's value and providing a potential boost to s...
